Immunomodulatory Mechanism and Potential Application of Dental Pulp-Derived Stem Cells in Immune-Mediated Diseases

Dental pulp stem cells (DPSCs) are mesenchymal stem cells (MSCs) derived from dental pulp tissue, which have high self-renewal ability and multi-lineage differentiation potential. With the discovery of the immunoregulatory ability of stem cells, DPSCs have attracted much attention because they have similar or even better immunomodulatory effects than MSCs from other sources. DPSCs and their exosomes can exert an immunomodulatory ability by acting on target immune cells to regulate cytokines. DPSCs can also migrate to the lesion site to differentiate into target cells to repair the injured tissue, and play an important role in tissue regeneration. The aim of this review is to summarize the molecular mechanism and target cells of the immunomodulatory effects of DPSCs, and the latest advances in preclinical research in the treatment of various immune-mediated diseases, providing new reflections for their clinical application. DPSCs may be a promising source of stem cells for the treatment of immune-mediated diseases.

[1]  Lina Yu,et al.  Cannabidiol Rescues TNF-α-Inhibited Proliferation, Migration, and Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells , 2023, Biomolecules.

[2]  O. Vivanco‐Rojas,et al.  Human Amniotic Membrane Mesenchymal Stem Cell-Synthesized PGE2 Exerts an Immunomodulatory Effect on Neutrophil Extracellular Trap in a PAD-4-Dependent Pathway through EP2 and EP4 , 2022, Cells.

[3]  Ouyang Qi,et al.  Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study , 2022, Signal Transduction and Targeted Therapy.

[4]  B. Lambermont,et al.  Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial , 2022, Frontiers in Immunology.

[5]  T. Yamaza,et al.  A New Target of Dental Pulp-Derived Stem Cell-Based Therapy on Recipient Bone Marrow Niche in Systemic Lupus Erythematosus , 2022, International journal of molecular sciences.

[6]  E. Candi,et al.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.

[7]  M. Ahmadi,et al.  Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications , 2022, Stem cell research & therapy.

[8]  Hua Wang,et al.  Dental pulp stem cell-derived exosomes suppress M1 macrophage polarization through the ROS-MAPK-NFκB P65 signaling pathway after spinal cord injury , 2022, Journal of Nanobiotechnology.

[9]  S. Steele,et al.  A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis , 2022, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[10]  C. Ricordi,et al.  Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up. , 2022, Cytotherapy.

[11]  M. Matin,et al.  Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial. , 2021, Current research in translational medicine.

[12]  P. Santamaria,et al.  Immunomodulatory and immunoregulatory nanomedicines for autoimmunity. , 2021, Seminars in immunology.

[13]  R. Tupler,et al.  Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells , 2021, Stem Cell Research & Therapy.

[14]  J. García-Sancho,et al.  Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis , 2021, Journal of translational medicine.

[15]  Y. Horiguchi,et al.  Efficacy of a cultured conditioned medium of exfoliated deciduous dental pulp stem cells in erectile dysfunction patients , 2021, Journal of cellular and molecular medicine.

[16]  Rasha H Al-Serwi,et al.  Human dental pulp stem cells attenuate streptozotocin-induced parotid gland injury in rats , 2021, Stem Cell Research & Therapy.

[17]  F. Al-Mulla,et al.  Dental Pulp Stem Cells Derived From Adult Human Third Molar Tooth: A Brief Review , 2021, Frontiers in Cell and Developmental Biology.

[18]  S. Hosseini,et al.  Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial , 2021, Stem Cell Research & Therapy.

[19]  E. Louis,et al.  Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. , 2021, Journal of Crohn's & colitis.

[20]  T. Nagao,et al.  Sustainable Effects of Human Dental Pulp Stem Cell Transplantation on Diabetic Polyneuropathy in Streptozotocine-Induced Type 1 Diabetes Model Mice , 2021, Cells.

[21]  Bo Zhang,et al.  Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial , 2021, eBioMedicine.

[22]  Shahriyar Abdoli,et al.  Cell therapy in patients with COVID-19 using Wharton’s jelly mesenchymal stem cells: a phase 1 clinical trial , 2021, Stem cell research & therapy.

[23]  Keke Zhang,et al.  Dental pulp stem cell‐derived exosomes alleviate cerebral ischaemia‐reperfusion injury through suppressing inflammatory response , 2021, Cell proliferation.

[24]  R. Guillamat-Prats.  The Role of MSC in Wound Healing, Scarring and Regeneration , 2021, Cells.

[25]  Yantian Chen,et al.  Comparative study of three types of mesenchymal stem cell to differentiate into pancreatic β-like cells in vitro , 2021, Experimental and therapeutic medicine.

[26]  F. Wei,et al.  Overexpression of hepatocyte growth factor in dental pulp stem cells ameliorates the severity of psoriasis by reducing inflammatory responses. , 2021, Stem cells and development.

[27]  H. Yamaza,et al.  Targeting of Deciduous Tooth Pulp Stem Cell–Derived Extracellular Vesicles on Telomerase-Mediated Stem Cell Niche and Immune Regulation in Systemic Lupus Erythematosus , 2021, The Journal of Immunology.

[28]  Chu-Tse Wu,et al.  Clinical-grade human dental pulp stem cells suppressed the activation of osteoarthritic macrophages and attenuated cartilaginous damage in a rabbit osteoarthritis model , 2021, Stem Cell Research & Therapy.

[29]  T. Ellmore,et al.  Allogeneic Bone Marrow–Derived Mesenchymal Stem Cell Safety in Idiopathic Parkinson's Disease , 2021, Movement disorders : official journal of the Movement Disorder Society.

[30]  M. Moriyama,et al.  Secreted factors from dental pulp stem cells improve Sjögren’s syndrome via regulatory T cell-mediated immunosuppression , 2021, Stem cell research & therapy.

[31]  M. Moriyama,et al.  Dental pulp-derived stem cell-conditioned media attenuates secondary Sjögren's syndrome via suppression of inflammatory cytokines in the submandibular glands , 2021, Regenerative therapy.

[32]  M. Janowski,et al.  Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases , 2021, Frontiers in Immunology.

[33]  M. Massari,et al.  Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients , 2021, Frontiers in Cell and Developmental Biology.

[34]  R. Caporali,et al.  The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives , 2021, Biomolecules.

[35]  Lanjuan Li,et al.  Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial , 2021, Clinical and translational medicine.

[36]  Ning Li,et al.  Dental pulp stem cells overexpressing hepatocyte growth factor facilitate the repair of DSS-induced ulcerative colitis , 2021, Stem cell research & therapy.

[37]  A. Alaiya,et al.  Proteomic Profiling of the First Human Dental Pulp Mesenchymal Stem/Stromal Cells from Carbonic Anhydrase II Deficiency Osteopetrosis Patients , 2020, International journal of molecular sciences.

[38]  Yun Chen,et al.  Inhibition of chondrocyte apoptosis in a rat model of osteoarthritis by exosomes derived from miR‑140‑5p‑overexpressing human dental pulp stem cells. , 2020, International journal of molecular medicine.

[39]  Dalong Zhu,et al.  One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study , 2020, Stem cell research & therapy.

[40]  J. Ling,et al.  MicroRNA-enriched small extracellular vesicles possess odonto-immunomodulatory properties for modulating the immune response of macrophages and promoting odontogenesis , 2020, Stem Cell Research & Therapy.

[41]  Ming Yan,et al.  Expansion of Human Dental Pulp Cells In Vitro Under Different Cryopreservation Conditions , 2020, In Vivo.

[42]  Jiyuan Zhang,et al.  Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial , 2020, Signal Transduction and Targeted Therapy.

[43]  K. Iohara,et al.  Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019 , 2020, Cell transplantation.

[44]  K. Shah,et al.  Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential. , 2020, Trends in pharmacological sciences.

[45]  Xiumei Wang,et al.  A Customized Self-Assembling Peptide Hydrogel-Wrapped Stem Cell Factor Targeting Pulp Regeneration Rich in Vascular-Like Structures , 2020, ACS Omega.

[46]  Chu-Tse Wu,et al.  Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II) , 2020, Trials.

[47]  C. Salvarani,et al.  AB0039 ROLE OF MESENCHYMAL STEM CELLS ISOLATED FROM DENTAL PULP (DPSCS) IN IMMUNOREGULATION PROCESSES MEDIATED BY PROGRAMMED DEATH-LIGAND 1 (PD-L1) , 2020, Annals of the Rheumatic Diseases.

[48]  Z. Zhang,et al.  THU0075 MIR-21 IN EXOSOMES DRIVED FROM DENTAL PULP STEM CELLS AMELIORATE THE TREGS/TH17 IMMUNE RESPONSE VIA TARGETING STAT3 IN COLLAGEN-INDUCED ARTHRITIS MICE , 2020 .

[49]  Ahmed Othman Fathy Othman El-Kersh,et al.  Transplantation of human dental pulp stem cells in streptozotocin-induced diabetic rats , 2020, Anatomical Science International.

[50]  R. Tupler,et al.  Modulation of Cell Death and Promotion of Chondrogenic Differentiation by Fas/FasL in Human Dental Pulp Stem Cells (hDPSCs) , 2020, Frontiers in Cell and Developmental Biology.

[51]  J. Vandeweerd,et al.  Therapeutic Potential of Dental Pulp Stem Cells and Leukocyte- and Platelet-Rich Fibrin for Osteoarthritis , 2020, Cells.

[52]  I. Angelopoulos,et al.  Cell-Based Regenerative Endodontics for Treatment of Periapical Lesions: A Randomized, Controlled Phase I/II Clinical Trial , 2020, Journal of dental research.

[53]  S. Metcalfe.  Mesenchymal stem cells and management of COVID-19 pneumonia , 2020, Medicine in Drug Discovery.

[54]  T. Zhang,et al.  DPSCs Attenuate Experimental Progressive TMJ Arthritis by Inhibiting the STAT1 Pathway , 2020, Journal of dental research.

[55]  B. Niu,et al.  Three-Dimensional Culture Promotes the Differentiation of Human Dental Pulp Mesenchymal Stem Cells Into Insulin-Producing Cells for Improving the Diabetes Therapy , 2020, Frontiers in Pharmacology.

[56]  X. Bai,et al.  Macrophages regulate the progression of osteoarthritis. , 2020, Osteoarthritis and cartilage.

[57]  H. Moutsopoulos,et al.  Sjögren's syndrome: Old and new therapeutic targets. , 2019, Journal of autoimmunity.

[58]  Manoj Kumar,et al.  Integrating omics for a better understanding of Inflammatory Bowel Disease: a step towards personalized medicine , 2019, Journal of Translational Medicine.

[59]  X. Rausch-Fan,et al.  Immunomodulatory properties of dental tissue-derived mesenchymal stem cells: Implication in disease and tissue regeneration , 2019, World journal of stem cells.

[60]  Yu-Show Fu,et al.  Reversal of bleomycin-induced rat pulmonary fibrosis by a xenograft of human umbilical mesenchymal stem cells from Wharton's jelly , 2019, Theranostics.

[61]  Qian Zhang,et al.  Stem cells  from exfoliated  deciduous  teeth alleviate hyposalivation caused by Sjögren syndrome. , 2019, Oral diseases.

[62]  Qiao Zhou,et al.  Comparison of immunomodulatory properties of exosomes derived from bone marrow mesenchymal stem cells and dental pulp stem cells , 2019, Immunologic Research.

[63]  P. Sharpe,et al.  Perivascular-Derived Mesenchymal Stem Cells , 2019, Journal of dental research.

[64]  D. Hommes,et al.  Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas , 2019, Journal of Crohn's & colitis.

[65]  C. Bao,et al.  Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial , 2019, Stem Cell Research & Therapy.

[66]  A. Naraghi,et al.  Bone Marrow Mesenchymal Stromal Cell Treatment in Patients with Osteoarthritis Results in Overall Improvement in Pain and Symptoms and Reduces Synovial Inflammation , 2019, Stem cells translational medicine.

[67]  O. Liu,et al.  Human dental pulp stem cells regulate allogeneic NK cells’ function via induction of anti‐inflammatory purinergic signalling in activated NK cells , 2019, Cell proliferation.

[68]  Hongwei Chen,et al.  Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice. , 2019, Annals of translational medicine.

[69]  R. Lechler,et al.  Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress , 2019, PloS one.

[70]  Gi Beom Kim,et al.  Intra‐Articular Injection of Autologous Adipose Tissue‐Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo‐Controlled Clinical Trial , 2019, Stem cells translational medicine.

[71]  P. Santamaria,et al.  Antigen-specific therapeutic approaches for autoimmunity , 2019, Nature Biotechnology.

[72]  F. Barry,et al.  Mesenchymal Stem Cell Therapy for Osteoarthritis: The Critical Role of the Cell Secretome , 2019, Front. Bioeng. Biotechnol..

[73]  J. Carballido,et al.  Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance , 2019, The Journal of experimental medicine.

[74]  M. Fayyad-kazan,et al.  Reciprocal immuno-biological alterations occur during the co-culture of natural killer cells and adipose tissue-derived mesenchymal stromal cells , 2019, Cytotechnology.

[75]  A. Khojasteh,et al.  Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells , 2019, Life sciences.

[76]  M. Vasei,et al.  Safety and efficacy of allogenic placental mesenchymal stem cells for treating knee osteoarthritis: a pilot study. , 2019, Cytotherapy.

[77]  F. Figueroa,et al.  Umbilical Cord‐Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial , 2018, Stem cells translational medicine.

[78]  N. Jaroughi,et al.  Intra-articular implantation of autologous bone marrow-derived mesenchymal stromal cells to treat knee osteoarthritis: a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. , 2018, Cytotherapy.

[79]  E. Andreu,et al.  Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II) , 2018, Journal of Translational Medicine.

[80]  M. Fayyad-kazan,et al.  Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells , 2018, Journal of cellular physiology.

[81]  E. Ramos,et al.  Autologous dental pulp mesenchymal stem cells for inferior third molar post-extraction socket healing: A split-mouth randomised clinical trial , 2018, Medicina oral, patologia oral y cirugia bucal.

[82]  E. Santiago-Osorio,et al.  Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: A case report , 2018, The Journal of international medical research.

[83]  T. Schumacher,et al.  Regulation and Function of the PD-L1 Checkpoint. , 2018, Immunity.

[84]  Yan Jin,et al.  PD-1 is required to maintain stem cell properties in human dental pulp stem cells , 2018, Cell Death & Differentiation.

[85]  D. Farber,et al.  Human T Cell Development, Localization, and Function throughout Life. , 2018, Immunity.

[86]  M. Fayyad-kazan,et al.  Immunological impact of Wharton’s Jelly mesenchymal stromal cells and natural killer cell co-culture , 2018, Molecular and Cellular Biochemistry.

[87]  M. Fayyad-kazan,et al.  Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation , 2018, Journal of Cell Communication and Signaling.

[88]  A. Sharpe,et al.  The diverse functions of the PD1 inhibitory pathway , 2017, Nature Reviews Immunology.

[89]  D. Majumdar,et al.  Functional recovery upon human dental pulp stem cell transplantation in a diabetic neuropathy rat model. , 2017, Cytotherapy.

[90]  C. Carda,et al.  In Vivo Articular Cartilage Regeneration Using Human Dental Pulp Stem Cells Cultured in an Alginate Scaffold: A Preliminary Study , 2017, Stem cells international.

[91]  Jung Hyun Lim,et al.  Immune Tolerance of Human Dental Pulp-Derived Mesenchymal Stem Cells Mediated by CD4+CD25+FoxP3+ Regulatory T-Cells and Induced by TGF-β1 and IL-10 , 2017, Yonsei medical journal.

[92]  A. Zapata,et al.  Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells , 2017, Stem Cell Research & Therapy.

[93]  D. Deng,et al.  A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis , 2017, Annals of the rheumatic diseases.

[94]  M. Ueda,et al.  Secreted Ectodomain of Sialic Acid‐Binding Ig‐Like Lectin‐9 and Monocyte Chemoattractant Protein‐1 Synergistically Regenerate Transected Rat Peripheral Nerves by Altering Macrophage Polarity , 2017, Stem cells.

[95]  J. Hua,et al.  Interactions between mesenchymal stem cells and the immune system , 2017, Cellular and Molecular Life Sciences.

[96]  Ceren Özel,et al.  The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets. , 2016, Cellular immunology.

[97]  B. Karabucak,et al.  DPSCs from Inflamed Pulp Modulate Macrophage Function via the TNF-α/IDO Axis , 2016, Journal of dental research.

[98]  M. Ferrari,et al.  Multipotent Differentiation of Human Dental Pulp Stem Cells: a Literature Review , 2016, Stem Cell Reviews and Reports.

[99]  F. Canovas,et al.  Adipose Mesenchymal Stromal Cell‐Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose‐Escalation Trial , 2016, Stem cells translational medicine.

[100]  L. Carey,et al.  TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke , 2016, International journal of stroke : official journal of the International Stroke Society.

[101]  Z. Yao,et al.  Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively , 2016, Journal of Translational Medicine.

[102]  M. Hoogduijn,et al.  Toward Development of iMesenchymal Stem Cells for Immunomodulatory Therapy , 2016, Front. Immunol..

[103]  J. Nakamura,et al.  Transplantation of dental pulp stem cells suppressed inflammation in sciatic nerves by promoting macrophage polarization towards anti‐inflammation phenotypes and ameliorated diabetic polyneuropathy , 2015, Journal of diabetes investigation.

[104]  N. H. Abu Kasim,et al.  Unique molecular signatures influencing the biological function and fate of post‐natal stem cells isolated from different sources , 2015, Journal of tissue engineering and regenerative medicine.

[105]  C. Ricordi,et al.  Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion , 2015, Diabetes Care.

[106]  Y. Hasegawa,et al.  Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice. , 2015, Cytotherapy.

[107]  J. García-Sancho,et al.  Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial , 2015, Transplantation.

[108]  H. Trivedi,et al.  Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. , 2015, Cytotherapy.

[109]  M. Pietropaolo,et al.  Immunogenetics of type 1 diabetes mellitus. , 2015, Molecular aspects of medicine.

[110]  K. Furukawa,et al.  Secreted Ectodomain of Sialic Acid-Binding Ig-Like Lectin-9 and Monocyte Chemoattractant Protein-1 Promote Recovery after Rat Spinal Cord Injury by Altering Macrophage Polarity , 2015, The Journal of Neuroscience.

[111]  Yi Liu,et al.  Dental pulp stem cells suppress the proliferation of lymphocytes via transforming growth factor-β1 , 2015, Human Cell.

[112]  R. Brunelli,et al.  The Fas/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem/progenitor cells. , 2014, Journal of hepatology.

[113]  Faming Chen,et al.  Investigation of dental pulp stem cells isolated from discarded human teeth extracted due to aggressive periodontitis. , 2014, Biomaterials.

[114]  O. Korsgren,et al.  Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells , 2014, Diabetes.

[115]  Y. Liu,et al.  TLR4 activation by lipopolysaccharide and Streptococcus mutans induces differential regulation of proliferation and migration in human dental pulp stem cells. , 2014, Journal of endodontics.

[116]  S. Sakaguchi,et al.  TREG-cell therapies for autoimmune rheumatic diseases , 2014, Nature Reviews Rheumatology.

[117]  G. Gilkeson,et al.  Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy , 2014, Clinical Rheumatology.

[118]  D. Roggenbuck,et al.  Diagnosis and classification of ulcerative colitis. , 2014, Autoimmunity reviews.

[119]  Lingyun Sun,et al.  Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study , 2014, Arthritis Research & Therapy.

[120]  V. Govindasamy,et al.  Comparison of immunodulatory properties of dental pulp stem cells derived from healthy and inflamed teeth , 2014, Clinical Oral Investigations.

[121]  G. Gilkeson,et al.  Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience , 2013, Cell transplantation.

[122]  R. Ribeiro‐dos‐Santos,et al.  Transplantation of Stem Cells Obtained from Murine Dental Pulp Improves Pancreatic Damage, Renal Function, and Painful Diabetic Neuropathy in Diabetic Type 1 Mouse Model , 2013, Cell transplantation.

[123]  P. Hytiroglou,et al.  Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation , 2013, Front. Immunol..

[124]  Ana Sánchez,et al.  Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells: A Pilot Study , 2013, Transplantation.

[125]  H. Yamaza,et al.  Immune Therapeutic Potential of Stem Cells from Human Supernumerary Teeth , 2013, Journal of dental research.

[126]  M. Peakman,et al.  Progress in immune‐based therapies for type 1 diabetes , 2013, Clinical and experimental immunology.

[127]  H. Zhang,et al.  Mesenchymal SCT ameliorates refractory cytopenia in patients with systemic lupus erythematosus , 2013, Bone Marrow Transplantation.

[128]  Fang Wang,et al.  Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. , 2013, Endocrine journal.

[129]  Z. Wang,et al.  LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells. , 2013, International endodontic journal.

[130]  H. Yamaza,et al.  Cryopreserved Dental Pulp Tissues of Exfoliated Deciduous Teeth Is a Feasible Stem Cell Resource for Regenerative Medicine , 2012, PloS one.

[131]  N. Kawashima.  Characterisation of dental pulp stem cells: a new horizon for tissue regeneration? , 2012, Archives of oral biology.

[132]  Steffen Jung,et al.  Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. , 2012, Immunity.

[133]  S. Shi,et al.  Fas Ligand Regulates the Immunomodulatory Properties of Dental Pulp Stem Cells , 2012, Journal of dental research.

[134]  A. Das,et al.  Mesenchymal stem cells for cartilage repair in osteoarthritis , 2012, Stem Cell Research & Therapy.

[135]  T. Cai,et al.  Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. , 2012, Cell stem cell.

[136]  Yuk-Kwan Chen,et al.  Human dental pulp stem cells derived from different cryopreservation methods of human dental pulp tissues of diseased teeth. , 2011, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[137]  E. Karaoz,et al.  Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems. , 2011, Cytotherapy.

[138]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[139]  S. Morbelli,et al.  Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells , 2011, Proceedings of the National Academy of Sciences.

[140]  Arnold I Caplan,et al.  The MSC: an injury drugstore. , 2011, Cell stem cell.

[141]  Zabedah A. Aziz,et al.  Differentiation of Dental Pulp Stem Cells into Islet-like Aggregates , 2011, Journal of dental research.

[142]  G. Supic,et al.  Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. , 2011, Stem cells and development.

[143]  Gabriel Courties,et al.  IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis , 2010, PloS one.

[144]  R. Weisel,et al.  Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair , 2010, Circulation.

[145]  D. Hommes,et al.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study , 2010, Gut.

[146]  Hong Wang,et al.  Extended Report , 2022 .

[147]  M. Corselli,et al.  Perivascular Ancestors of Adult Multipotent Stem Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[148]  N. Cacalano,et al.  Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity , 2010, PloS one.

[149]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[150]  S. Gronthos,et al.  Immunomodulatory properties of human periodontal ligament stem cells , 2009, Journal of cellular physiology.

[151]  S. Itakura,et al.  Mesenchymal stem cells suppress B-cell terminal differentiation. , 2009, Experimental hematology.

[152]  B. Blanco,et al.  The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes , 2008, Haematologica.

[153]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.

[154]  P. Tak,et al.  Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation , 2007 .

[155]  A. Uccelli,et al.  Mesenchymal stem cells: a new strategy for immunosuppression? , 2007, Trends in immunology.

[156]  O. Ringdén,et al.  Mesenchymal Stem Cells Stimulate Antibody Secretion in Human B Cells , 2007, Scandinavian journal of immunology.

[157]  Ly Sun,et al.  Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus , 2007, Lupus.

[158]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[159]  Stephen C. Jones,et al.  CD4+ T‐cell memory: generation and multi‐faceted roles for CD4+ T cells in protective immunity to influenza , 2006, Immunological reviews.

[160]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[161]  L. Moretta,et al.  Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. , 2006, Blood.

[162]  M. Larché.  A short review of the pathogenesis of Sjögren's syndrome. , 2006, Autoimmunity reviews.

[163]  M. Albert,et al.  A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. , 2005, Blood.

[164]  Mario Calvitti,et al.  Multipotent Mesenchymal Stem Cells with Immunosuppressive Activity Can Be Easily Isolated from Dental Pulp , 2005, Transplantation.

[165]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[166]  M. Sykes,et al.  Treatment of severe autoimmune disease by stem-cell transplantation , 2005, Nature.

[167]  Yi Zhang,et al.  Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.

[168]  P. Dieppe,et al.  Pathogenesis and management of pain in osteoarthritis , 2005, The Lancet.

[169]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[170]  A. Flake,et al.  Mesenchymal stem cells: paradoxes of passaging. , 2004, Experimental hematology.

[171]  M. Gershwin,et al.  Immunopathogenesis of Sjögren's syndrome , 2003, Clinical reviews in allergy & immunology.

[172]  Michel C. Nussenzweig,et al.  Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[173]  A. Gratwohl,et al.  Stem cell transplantation for autoimmune diseases. , 2001, Best practice & research. Clinical haematology.

[174]  H. Moutsopoulos,et al.  Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. , 2001, Journal of autoimmunity.

[175]  S. Gronthos,et al.  Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[176]  R. Fox,et al.  Sjögren's syndrome , 1995, The Lancet.

[177]  N. Young,et al.  Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. , 1995, Blood.

[178]  M. Kiriakidou,et al.  Systemic Lupus Erythematosus , 1991, Annals of Internal Medicine.

[179]  H. Das,et al.  Development of Cutaneous Wound in Diabetic Immunocompromised Mice and Use of Dental Pulp-Derived Stem Cell Product for Healing. , 2021, Methods in molecular biology.

[180]  Jung Min Lee,et al.  Human Dental Pulp Stem Cells Suppress Alloantigen‐induced Immunity by Stimulating T Cells to Release Transforming Growth Factor Beta , 2017, Journal of endodontics.

[181]  Xiaowen He,et al.  Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn’s Disease , 2016, Digestive Diseases and Sciences.

[182]  I. Guleria,et al.  Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus , 2015, Biomedical journal.

[183]  Yaqing Zhang,et al.  Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells. , 2014, Journal of endodontics.

[184]  D. Bresson,et al.  Progress in the Development of Immune-Based Therapies for Type 1 Diabetes Mellitus , 2012, BioDrugs.

[185]  A. Parfenov,et al.  [Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation]. , 2010, Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology.

[186]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer – cell proliferation , cytotoxicity , and cytokine production : role of indoleamine 2 , 3-dioxygenase and prostaglandin E 2 , 2008 .

[187]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[188]  R. Biassoni,et al.  Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.